Clinical trial underway for potential Long Covid treatment.
"A clinical trial is underway to assess the effectiveness and safety of Sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against COVID-19, as a potential treatment for Long Covid."
Source: https://silc.org/news/clinical-trial-underway-for-potential-long-covid-treatment/